Market Research Logo

Anaphylaxis - Pipeline Review, H2 2018

Anaphylaxis - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaphylaxis - Pipeline Review, H2 2018, provides an overview of the Anaphylaxis (Immunology) pip


Introduction
Global Markets Direct Report Coverage
Anaphylaxis - Overview
Anaphylaxis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Anaphylaxis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Anaphylaxis - Companies Involved in Therapeutics Development
Aquestive Therapeutics Inc
Insys Therapeutics Inc
MannKind Corp
Merck & Co Inc
Shenox Pharmaceuticals LLC
Anaphylaxis - Drug Profiles
epinephrine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
epinephrine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
epinephrine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibody to Antagonize FcgR1 for Autoimmune Arthritis, Pulmonary Inflammation, Systemic Anaphylaxis and Thrombocytopenia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Monoclonal Antibody to Antagonize FcgRIIa for Autoimmune Arthritis, Pulmonary Inflammation, Systemic Anaphylaxis and Thrombocytopenia - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SHX-008 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
XL-499 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Anaphylaxis - Dormant Projects
Anaphylaxis - Product Development Milestones
Featured News & Press Releases
Aug 30, 2018: FDA Grants INSYS Therapeutics Fast Track Designation for Epinephrine Nasal Spray as Investigational Treatment for Anaphylaxis
Jun 14, 2018: Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promise as Potential Alternative to Intramuscular Injection
Dec 07, 2017: INSYS Therapeutics Starts Proof-of-Concept Study of Epinephrine Nasal Spray for Anaphylaxis
Jan 10, 2017: MonoSol Rx to Initiate Human Proof-of-Concept Study of Epinephrine Sublingual Soluble Film
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Anaphylaxis, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Anaphylaxis - Pipeline by Aquestive Therapeutics Inc, H2 2018
Anaphylaxis - Pipeline by Insys Therapeutics Inc, H2 2018
Anaphylaxis - Pipeline by MannKind Corp, H2 2018
Anaphylaxis - Pipeline by Merck & Co Inc, H2 2018
Anaphylaxis - Pipeline by Shenox Pharmaceuticals LLC, H2 2018
Anaphylaxis - Dormant Projects, H2 2018
List of Figures
Number of Products under Development for Anaphylaxis, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Targets, H2 2018
Number of Products by Stage and Targets, H2 2018
Number of Products by Mechanism of Actions, H2 2018
Number of Products by Stage and Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report